Raising Growth Capital Through a Listing and Public Offering
First written in FY2023. 8 of 9 entries say "Advanced", first in FY2024-Q1. Latest entry: FY2026.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「2 July 2025–30 June 2026 (Note 5) 1,070,100 shares」
The Company issued 1,070,100 shares during the fiscal year through the exercise of share acquisition rights, increasing capital and capital surplus by ¥77 million each. It continued to secure growth funding and strengthen its capital base following its listing. - FY2026-H1AdvancedAnnual report
「Between 1 July 2025 and 31 December 2025, the total number of issued shares increased by 783,720 through the exercise of stock acquisition rights, while capital stock and the capital reserve increased by ¥54 million each.」
The exercise of stock acquisition rights resulted in the issuance of 783,720 shares during the interim consolidated accounting period, increasing capital stock and the capital reserve by ¥54 million each. - FY2025AdvancedAnnual report
「New shares issued: increase through restricted stock compensation, 5,940 shares; increase through exercise of stock acquisition rights, 164,670 shares」
During the fiscal year, 5,940 shares were issued as restricted stock compensation and 164,670 shares through the exercise of stock acquisition rights, increasing capital stock and capital surplus by ¥68 million each. - FY2025-H1AdvancedAnnual report
「1 July 2024 to 31 December 2024 74,190 Increase due to the exercise of stock acquisition rights.」
During the interim consolidated accounting period, the number of issued shares increased by 74,190 through the exercise of stock acquisition rights and other transactions, while capital stock and the capital reserve increased by ¥32 million each. - FY2024AdvancedAnnual report
「New shares issued consisted of 1,050,000 shares through a paid public offering, 157,500 shares through a private placement, 12,014 shares as restricted stock compensation and 122,220 shares through the exercise of stock acquisition rights.」
In addition to the public offering and private placement associated with the listing, 122,220 shares were issued through the exercise of stock acquisition rights during the fiscal year, bringing capital stock to ¥1,093 million and capital surplus to ¥2,701 million. - FY2024-Q3AdvancedAnnual report
「In addition, the exercise of stock acquisition rights (stock options) during the second quarter consolidated accounting period increased capital stock and capital surplus by ¥35 million each, while the exercise of stock acquisition rights (stock options) during the third quarter consolidated accounting period increased each by ¥8 million. As a result, at the end of the third quarter consolidated accounting period, capital stock stood at ¥1,088 million and capital surplus at ¥2,697 million.」
The exercise of stock acquisition rights during the third quarter accounting period increased the number of shares by 13,770 and increased capital stock and capital surplus by ¥8 million each. - FY2024-Q2AdvancedAnnual report
「In addition, the exercise of stock acquisition rights (stock options) during the second quarter consolidated accounting period increased capital stock and capital surplus by ¥35 million each. As a result, at the end of the second quarter consolidated accounting period, capital stock stood at ¥1,080 million and capital surplus at ¥2,689 million.」
The exercise of stock acquisition rights after the listing resulted in the issuance of 91,590 shares and increased capital stock and capital surplus by ¥35 million each. Including the capital increase associated with the listing, capital stock stood at ¥1,080 million and capital surplus at ¥2,689 million at period-end. - FY2024-Q1AdvancedAnnual report
「In connection with the offering for sale through an over-allotment, the company resolved to issue new shares through a private placement with the company as the allottee, as follows, and payment was completed on 24 October 2023. Type and number of shares to be issued: common shares, 157,500 shares. Total allotment price: ¥244 million. The proceeds were planned for investments and loans to expand aquaculture facilities at the consolidated subsidiary 日本サーモンファーム株式会社 and to fund factory equipment at the company.」
Payment for the additional private placement associated with the listing was completed, raising growth capital of 157,500 shares and ¥244 million, with the proceeds allocated to aquaculture and factory equipment. - FY2023First statedAnnual report
「In connection with the listing, the Board of Directors resolved at its meeting held on 24 August 2023 to issue new shares through a public offering as follows, and payment was completed on 26 September 2023.」
The company listed on the Tokyo Stock Exchange Standard Market in September 2023 and planned to use the proceeds from the public offering to expand aquaculture facilities at 日本サーモンファーム and fund factory equipment.